Research shows that while on immunotherapy, plasma levels of PD-L1 expression can be used in order to monitor clinical responses....
Culver City, California and San Diego – June 19, 2018 – NantHealth (NASDAQ: NH), a next-generation healthcare company, will exhibit and present...
7:02 pm MST | Jun 8, 2018 | BioCentury | Product Development POC FOR CYTOKINES Cytokines are emerging as a...
Soon-Shiong offers insights on research and development efforts, clinical update during presentation in New York. NEW YORK CITY, June 7...
Results to be presented during the tumor biology session at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting...
Results to be presented during the tumor biology session at the ASCO 2018 Annual Meeting CHICAGO, IL – June 4,...
Results to be presented during the tumor biology session at the ASCO 2018 Annual Meeting CHICAGO, IL – June 4,...
Molecular test allows for continuous, noninvasive monitoring and tumor profiling CHICAGO— June 2, 2018 – NantHealth, Inc., (NASDAQ: NH), a...
Results to be presented during the tumor biology session at the ASCO 2018 Annual Meeting CHICAGO, IL – June 4,...
Research shows approach that includes sequencing both normal genomes and tumor genomes increases accuracy and precision Culver City, CA – May...
Platinum sponsor NantHealth will showcase GPS Cancer® and precision medicine solutions for oncology at booth #314 Culver City, California and...
Dr. Patrick Soon-Shiong Presents at the 36th Annual J.P. Morgan Healthcare Conference Download Presentation (PDF) Dr. Patrick Soon-Shiong Presents at...